S&P 500   3,103.01 (-0.55%)
DOW   27,777.24 (-0.56%)
QQQ   201.46 (-0.94%)
BABA   182.01 (-1.75%)
T   37.07 (-2.47%)
DIS   146.36 (-1.36%)
S&P 500   3,103.01 (-0.55%)
DOW   27,777.24 (-0.56%)
QQQ   201.46 (-0.94%)
BABA   182.01 (-1.75%)
T   37.07 (-2.47%)
DIS   146.36 (-1.36%)
S&P 500   3,103.01 (-0.55%)
DOW   27,777.24 (-0.56%)
QQQ   201.46 (-0.94%)
BABA   182.01 (-1.75%)
T   37.07 (-2.47%)
DIS   146.36 (-1.36%)
S&P 500   3,103.01 (-0.55%)
DOW   27,777.24 (-0.56%)
QQQ   201.46 (-0.94%)
BABA   182.01 (-1.75%)
T   37.07 (-2.47%)
DIS   146.36 (-1.36%)
Log in

THERAPIX BIOSCI/S News Headlines (NASDAQ:TRPX)

$1.52
-0.12 (-7.32 %)
(As of 11/20/2019 03:32 PM ET)
Today's Range
$1.50
Now: $1.52
$1.60
50-Day Range
$1.49
MA: $2.28
$2.62
52-Week Range
$1.40
Now: $1.52
$8.00
Volume1,225 shs
Average Volume122,706 shs
Market Capitalization$5.34 million
P/E RatioN/A
Dividend YieldN/A
Beta0.86

Headlines

THERAPIX BIOSCI/S (NASDAQ TRPX) News Headlines

Source:
DateHeadline
Therapix Pursues Reverse Merger With CBD Wellness Company Heavenly RxTherapix Pursues Reverse Merger With CBD Wellness Company Heavenly Rx
finance.yahoo.com - November 19 at 6:34 PM
The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy ReadoutThe Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy Readout
www.benzinga.com - November 19 at 8:33 AM
Therapix Biosciences Announces Positive Topline Results From Phase IIa Clinical Trial of THX-110 for Obstructive Sleep Apnea ProgramTherapix Biosciences Announces Positive Topline Results From Phase IIa Clinical Trial of THX-110 for Obstructive Sleep Apnea Program
finance.yahoo.com - November 13 at 3:17 PM
Therapix Biosciences and Destiny Biosciences Global Corp. Mutually Decide to Discontinue Negotiations on Planned MergerTherapix Biosciences and Destiny Biosciences Global Corp. Mutually Decide to Discontinue Negotiations on Planned Merger
finance.yahoo.com - November 7 at 7:45 PM
Therapix Biosciences Announces Positive Data From Recent Pre-clinical Study for New Drug Candidate THX-210Therapix Biosciences Announces Positive Data From Recent Pre-clinical Study for New Drug Candidate THX-210
finance.yahoo.com - October 15 at 12:22 PM
21 Stocks Moving in Thursdays Pre-Market Session21 Stocks Moving in Thursday's Pre-Market Session
www.msn.com - October 3 at 8:30 PM
Nasdaq Grants Therapix Biosciences Extension to Comply With Stockholders Equity RequirementNasdaq Grants Therapix Biosciences Extension to Comply With Stockholders' Equity Requirement
finance.yahoo.com - August 27 at 10:18 AM
Therapix Bios CannAmide OKd in Canada; shares ahead 5%Therapix Bio's CannAmide OK'd in Canada; shares ahead 5%
seekingalpha.com - July 31 at 5:16 PM
Therapix Biosciences Announces Canadian Product License Issuance for TheraPEA (CannAmide™), a Non-Opiate Based Pain Management SupplementTherapix Biosciences Announces Canadian Product License Issuance for TheraPEA (CannAmide™), a Non-Opiate Based Pain Management Supplement
finance.yahoo.com - July 31 at 10:15 AM
Cannabis M&A: Therapix Biosciences, Destiny Biosciences Plan Stock-For-Stock DealCannabis M&A: Therapix Biosciences, Destiny Biosciences Plan Stock-For-Stock Deal
www.benzinga.com - July 23 at 11:31 AM
Therapix Biosciences Signs LOI to Merge With Destiny Biosciences Global Corp. in a Stock for Stock Transaction Valuing Therapix at US$48 MillionTherapix Biosciences Signs LOI to Merge With Destiny Biosciences Global Corp. in a Stock for Stock Transaction Valuing Therapix at US$48 Million
finance.yahoo.com - July 23 at 11:31 AM
Therapix Biosciences Announces First Quarter 2019 Condensed Financial DataTherapix Biosciences Announces First Quarter 2019 Condensed Financial Data
finance.yahoo.com - July 17 at 5:07 PM
Therapix Biosciences Announces Interim Results of Phase IIa Study at Assuta Medical Center for Obstructive Sleep Apnea ProgramTherapix Biosciences Announces Interim Results of Phase IIa Study at Assuta Medical Center for Obstructive Sleep Apnea Program
finance.yahoo.com - June 28 at 5:09 PM
Therapix Biosciences Issues Shareholder Update LetterTherapix Biosciences Issues Shareholder Update Letter
finance.yahoo.com - May 29 at 9:44 AM
Therapix Biosciences Ltd. ADRTherapix Biosciences Ltd. ADR
www.barrons.com - May 24 at 5:50 PM
The Daily Biotech Pulse: FDA Nod For Novocure, Dynavax Restructures, Therapix Receives Nasdaq NoticeThe Daily Biotech Pulse: FDA Nod For Novocure, Dynavax Restructures, Therapix Receives Nasdaq Notice
www.benzinga.com - May 24 at 9:52 AM
Therapix Biosciences Announces Pricing of $2.25 Million Registered Direct OfferingTherapix Biosciences Announces Pricing of $2.25 Million Registered Direct Offering
finance.yahoo.com - March 28 at 10:03 AM
Therapix Biosciences Appoints Ambassador Ron Prosor as Executive AdvisorTherapix Biosciences Appoints Ambassador Ron Prosor as Executive Advisor
finance.yahoo.com - March 19 at 10:05 AM
Cannabis Stock News Weekend Roundup December 23Cannabis Stock News Weekend Roundup December 23
finance.yahoo.com - December 23 at 9:12 AM
FSD Pharma still interested in synthetic cannabinoidFSD Pharma still interested in synthetic cannabinoid
seekingalpha.com - December 22 at 9:29 AM
Therapix Biosciences Terminates FSD Acquisition Letter of IntentTherapix Biosciences Terminates FSD Acquisition Letter of Intent
finance.yahoo.com - December 21 at 9:33 AM
Therapix Biosciences Reports Third Quarter 2018 Financial Results and Provides Business UpdateTherapix Biosciences Reports Third Quarter 2018 Financial Results and Provides Business Update
finance.yahoo.com - December 3 at 9:42 AM
Therapix Biosciences Clarifies Terms of Recently Issued Convertible DebentureTherapix Biosciences Clarifies Terms of Recently Issued Convertible Debenture
finance.yahoo.com - November 30 at 10:23 AM
Therapix Biosciences Issues $1,500,000 Convertible DebentureTherapix Biosciences Issues $1,500,000 Convertible Debenture
finance.yahoo.com - November 27 at 10:13 AM
Earnings movers top premarket losers listEarnings movers top premarket losers list
seekingalpha.com - November 6 at 4:22 PM
Mid-Afternoon Market Update: Crude Oil Down Over 4%; Therapix Biosciences Shares Spike HigherMid-Afternoon Market Update: Crude Oil Down Over 4%; Therapix Biosciences Shares Spike Higher
www.benzinga.com - October 23 at 4:13 PM
Therapix Takes off on Sale to FSDTherapix Takes off on Sale to FSD
www.baystreet.ca - October 23 at 4:13 PM
Small medical pot companies plan to merge in $48 million stock dealSmall medical pot companies plan to merge in $48 million stock deal
www.marketwatch.com - October 23 at 9:35 AM
Stock Market News Daily Roundup October 23Stock Market News Daily Roundup October 23
finance.yahoo.com - October 23 at 9:35 AM
Therapix Biosciences, Cannabis Based Drug Candidates Pipeline ReviewTherapix Biosciences, Cannabis Based Drug Candidates Pipeline Review
finance.yahoo.com - October 5 at 9:28 AM
Therapix Biosciences Reports Second Quarter 2018 Financial Results and Provides Business UpdateTherapix Biosciences Reports Second Quarter 2018 Financial Results and Provides Business Update
finance.yahoo.com - August 20 at 9:56 AM
Therapix Bio up 13% premarket on preclinical data on lead drug THX-160Therapix Bio up 13% premarket on preclinical data on lead drug THX-160
seekingalpha.com - July 17 at 4:05 PM
Therapix Biosciences (TRPX) Reports Positive Data From Pre-clinical Studies for THX-160 for Treatment of PainTherapix Biosciences (TRPX) Reports Positive Data From Pre-clinical Studies for THX-160 for Treatment of Pain
www.streetinsider.com - July 17 at 9:10 AM
Therapix Biosciences Announces Positive Data From Recent Pre-clinical Studies for its Drug Candidate THX-160 for Treatment of PainTherapix Biosciences Announces Positive Data From Recent Pre-clinical Studies for its Drug Candidate THX-160 for Treatment of Pain
finance.yahoo.com - July 17 at 9:10 AM
Therapix Biosciences Signs Term Sheet for the Transfer of Non-Pain Cannabinoid-Based Drug Pipeline Assets to Cure PharmaceuticalTherapix Biosciences Signs Term Sheet for the Transfer of Non-Pain Cannabinoid-Based Drug Pipeline Assets to Cure Pharmaceutical
finance.yahoo.com - July 12 at 9:17 AM
Cure Pharmaceutical Plans to Acquire Cannabinoid-Based Drug Pipeline from Therapix Biosciences Ltd.Cure Pharmaceutical Plans to Acquire Cannabinoid-Based Drug Pipeline from Therapix Biosciences Ltd.
finance.yahoo.com - July 11 at 9:08 AM
Therapix Biosciences Updates Regarding TASE DelistingTherapix Biosciences Updates Regarding TASE Delisting
finance.yahoo.com - June 27 at 11:44 AM
Form F-3 Therapix BiosciencesForm F-3 Therapix Biosciences
www.streetinsider.com - June 22 at 11:25 AM
Therapix Biosciences Sponsors the 2018 Annual Meeting of the European Society for the Study of Tourette SyndromeTherapix Biosciences Sponsors the 2018 Annual Meeting of the European Society for the Study of Tourette Syndrome
finance.yahoo.com - June 12 at 9:24 AM
Therapix Biosciences (TRPX) Reports First Patient Enrollment for Clinical Trial at Assuta Medical Center for Treating Obstructive Sleep ApneaTherapix Biosciences (TRPX) Reports First Patient Enrollment for Clinical Trial at Assuta Medical Center for Treating Obstructive Sleep Apnea
www.streetinsider.com - June 6 at 9:46 AM
Therapix Biosciences Reports First Quarter 2018 Financial Results and Provides Business UpdateTherapix Biosciences Reports First Quarter 2018 Financial Results and Provides Business Update
finance.yahoo.com - June 1 at 9:44 AM
Therapix Biosciences Issues CEOs Letter to ShareholdersTherapix Biosciences Issues CEO's Letter to Shareholders
finance.yahoo.com - May 15 at 10:18 AM
Dual-Listed Therapix to Voluntarily Delist from Tel Aviv Stock ExchangeDual-Listed Therapix to Voluntarily Delist from Tel Aviv Stock Exchange
finance.yahoo.com - May 9 at 9:43 AM
Today’s Research Reports on Stocks to Watch: Teva and TherapixToday’s Research Reports on Stocks to Watch: Teva and Therapix
finance.yahoo.com - April 10 at 10:08 AM
Therapix Biosciences Announces Topline Results of Phase IIa Study at Yale University for Tourette Syndrome ProgramTherapix Biosciences Announces Topline Results of Phase IIa Study at Yale University for Tourette Syndrome Program
finance.yahoo.com - April 9 at 9:57 AM
Therapix shares surge 30% premarket on news of positive trial of Tourette syndrome treatmentTherapix shares surge 30% premarket on news of positive trial of Tourette syndrome treatment
finance.yahoo.com - April 9 at 9:57 AM
Therapix Biosciences Announces FDA Clearance of Investigational New Drug (IND) for Phase IIa Clinical Trial of THX-110 in the Treatment of Chronic Low Back PainTherapix Biosciences Announces FDA Clearance of Investigational New Drug (IND) for Phase IIa Clinical Trial of THX-110 in the Treatment of Chronic Low Back Pain
finance.yahoo.com - March 20 at 9:55 AM
Therapix Biosciences Completes Pre-IND Communication With FDA on THX-110 for Tourette Syndrome: Clinical Development to Proceed as ProjectedTherapix Biosciences Completes Pre-IND Communication With FDA on THX-110 for Tourette Syndrome: Clinical Development to Proceed as Projected
finance.yahoo.com - February 7 at 9:03 AM
Therapix Biosciences Announces Expansion into Precision Medicine Through New Fully-Owned Subsidiary and Provides Corporate Update Today at the Biotech Showcase™ 2018Therapix Biosciences Announces Expansion into Precision Medicine Through New Fully-Owned Subsidiary and Provides Corporate Update Today at the Biotech Showcase™ 2018
finance.yahoo.com - January 9 at 9:05 AM
Therapix Biosciences (TRPX) Completes Enrollment of Phase IIa Study at Yale University for Tourette Syndrome ProgramTherapix Biosciences (TRPX) Completes Enrollment of Phase IIa Study at Yale University for Tourette Syndrome Program
www.streetinsider.com - December 5 at 5:42 PM
This page was last updated on 11/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel